Back to top

Bank of America Securities Remains a Buy on Werewolf Therapeutics (HOWL)

In a report released yesterday, Jason Zemansky from Bank of America Securities reiterated a Buy rating on Werewolf Therapeutics (HOWL – Research Re...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Werewolf Therapeutics, Inc. (HOWL)